Novel targeted drugs for follicular and marginal zone lymphoma: a comprehensive review

Although mostly incurable, indolent non-Hodgkin lymphomas (iNHL) are chronic diseases with a median overall survival approaching 20 years. In recent years, important advances in the knowledge of the biology of these lymphomas have led to the development of new drugs, mostly chemotherapy-free, with p...

Full description

Bibliographic Details
Main Authors: Andrea Rivero, Pablo Mozas, Laura Magnano, Armando López-Guillermo
Format: Article
Language:English
Published: Frontiers Media S.A. 2023-05-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2023.1170394/full